Smead Capital Management, Inc. has added 1,624,138 shares of $FITB to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $FITB.
FIFTH THIRD BAN Hedge Fund Activity
We have seen 501 institutional investors add shares of FIFTH THIRD BAN stock to their portfolio, and 451 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 5,416,148 shares (+27.5%) to their portfolio in Q3 2025, for an estimated $241,289,393
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,002,398 shares (+104.8%) to their portfolio in Q3 2025, for an estimated $222,856,830
- MARSHALL WACE, LLP added 2,342,624 shares (+1854.5%) to their portfolio in Q3 2025, for an estimated $104,363,899
- BANK OF AMERICA CORP /DE/ added 2,293,439 shares (+16.7%) to their portfolio in Q3 2025, for an estimated $102,172,707
- ALECTA TJANSTEPENSION OMSESIDIGT added 1,907,400 shares (+130.6%) to their portfolio in Q4 2025, for an estimated $89,285,394
- CAPITAL WORLD INVESTORS added 1,803,861 shares (+6.2%) to their portfolio in Q3 2025, for an estimated $80,362,007
- SMEAD CAPITAL MANAGEMENT, INC. added 1,624,138 shares (+99.9%) to their portfolio in Q4 2025, for an estimated $76,025,899
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FIFTH THIRD BAN Insider Trading Activity
FIFTH THIRD BAN insiders have traded $FITB stock on the open market 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $FITB stock by insiders over the last 6 months:
- KEVIN J KHANNA (EVP) sold 14,000 shares for an estimated $597,426
- EVAN BAYH has made 2 purchases buying 3,000 shares for an estimated $123,650 and 0 sales.
- JUDE SCHRAMM (EVP & CIO) sold 2,250 shares for an estimated $109,125
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FIFTH THIRD BAN Analyst Ratings
Wall Street analysts have issued reports on $FITB in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/05/2026
- Piper Sandler issued a "Overweight" rating on 12/10/2025
- TD Cowen issued a "Buy" rating on 10/20/2025
- DA Davidson issued a "Buy" rating on 10/08/2025
- Morgan Stanley issued a "Overweight" rating on 10/07/2025
- Truist Securities issued a "Buy" rating on 09/12/2025
To track analyst ratings and price targets for FIFTH THIRD BAN, check out Quiver Quantitative's $FITB forecast page.
FIFTH THIRD BAN Price Targets
Multiple analysts have issued price targets for $FITB recently. We have seen 13 analysts offer price targets for $FITB in the last 6 months, with a median target of $57.0.
Here are some recent targets:
- John Pancari from Evercore ISI Group set a target price of $57.0 on 02/05/2026
- Steven Alexopoulos from TD Cowen set a target price of $60.0 on 02/03/2026
- Peter Winter from DA Davidson set a target price of $58.0 on 01/26/2026
- Brian Foran from Truist Securities set a target price of $60.0 on 01/26/2026
- Keith Horowitz from Citigroup set a target price of $53.0 on 01/23/2026
- Gerard Cassidy from RBC Capital set a target price of $57.0 on 01/21/2026
- David Konrad from Keefe, Bruyette & Woods set a target price of $55.0 on 01/21/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $FITB ticker page for more data.
